» Articles » PMID: 26647069

Age-related Neuroinflammation and Changes in AKT-GSK-3β and WNT/ β-CATENIN Signaling in Rat Hippocampus

Overview
Specialty Geriatrics
Date 2015 Dec 10
PMID 26647069
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is a multifactorial process associated with an increased susceptibility to neurodegenerative disorders which can be related to chronic inflammation. Chronic inflammation, however, can be characterized by the persistent elevated glucocorticoid (GCs) levels, activation of the proinflammatory transcription factor NF-кB, as well as an increase in cytokines. Interestingly, both NF-кB and cytokines can be even modulated by Glycogen Synthase Kinase 3 beta (GSK-3β) activity, which is a key protein that can intermediate inflammation and metabolism, once it has a critical role in AKT signaling pathway, and can also intermediate WNT/β-CATENIN signaling pathway. The aim of this study was to verify age-related changes in inflammatory status, as well as in the AKT and WNT signaling pathways. Results showed an age-related increase in neuroinflammation as indicated by NF-кB activation, TNF-α and GCs increased levels, a decrease in AKT activation and an increase in GSK-3β activity in both 12- and 24- month old animals. Aging also seems to induce a progressive decrease in canonical WNT/β-CATENIN signaling pathway once there is a decrease in DVL-2 levels and in the transcription of Axin2 gene. Little is known about the DVL-2 regulation as well as its roles in WNT signaling pathway, but for the first time it was suggested that DVL-2 expression can be changed along aging.

Citing Articles

Inflammaging and Brain Aging.

Jurcau M, Jurcau A, Cristian A, Hogea V, Diaconu R, Nunkoo V Int J Mol Sci. 2024; 25(19).

PMID: 39408862 PMC: 11476611. DOI: 10.3390/ijms251910535.


Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue.

Turkistani A, Al-Kuraishy H, Al-Gareeb A, Albuhadily A, Alexiou A, Papadakis M Mol Neurobiol. 2024; 61(9):7092-7108.

PMID: 38367137 PMC: 11338983. DOI: 10.1007/s12035-024-04003-z.


Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism.

Khalilpour J, Zangbar H, Alipour M, Pakdel F, Zavari Z, Shahabi P Mol Neurobiol. 2023; 61(6):3121-3143.

PMID: 37976025 DOI: 10.1007/s12035-023-03763-4.


The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression.

Kostes W, Brafman D Cells. 2023; 12(8).

PMID: 37190113 PMC: 10136584. DOI: 10.3390/cells12081204.


A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer's disease.

Jones M, Buchler J, Dufor T, Palomer E, Teo S, Martin-Flores N Sci Adv. 2023; 9(2):eabo7421.

PMID: 36638182 PMC: 10624429. DOI: 10.1126/sciadv.abo7421.


References
1.
Ciani L, Krylova O, Smalley M, Dale T, Salinas P . A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules. J Cell Biol. 2004; 164(2):243-53. PMC: 2172322. DOI: 10.1083/jcb.200309096. View

2.
McKay L, Cidlowski J . CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol. 2000; 14(8):1222-34. DOI: 10.1210/mend.14.8.0506. View

3.
Emami K, Nguyen C, Ma H, Kim D, Jeong K, Eguchi M . A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A. 2004; 101(34):12682-7. PMC: 515116. DOI: 10.1073/pnas.0404875101. View

4.
De Ferrari G, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila M, Major M . Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 2007; 104(22):9434-9. PMC: 1890512. DOI: 10.1073/pnas.0603523104. View

5.
Jho E, Zhang T, Domon C, Joo C, Freund J, Costantini F . Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002; 22(4):1172-83. PMC: 134648. DOI: 10.1128/MCB.22.4.1172-1183.2002. View